AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.2700
-0.0090 (-3.23%)
At close: Oct 5, 2026, 4:00 PM EDT
0.2668
-0.0032 (-1.19%)
Pre-market: Oct 6, 2026, 8:44 AM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $13.47 million as of October 5, 2026. Its market cap has increased by 42.80% in one year.
Market Cap
13.47M
Enterprise Value
12.81M
1-Year Change
42.80%
Ranking
Category
Stock Price
$0.27
ChartMarket Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $13.47M, a decrease of -78.84%. That is a compound annual growth rate of -24.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 13.47M | 3.43% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 15.34M |
| Citius Pharmaceuticals | 14.59M |
| IN8bio | 13.80M |
| Niki BioSolutions | 13.52M |
| Tempest Therapeutics | 13.42M |
| Vyome Holdings | 13.41M |
| Passage Bio | 13.26M |
| Lisata Therapeutics | 13.25M |